Discontinued — last reported Q3 '24
Labcorp Holdings LabCorp Diagnostics — Percent of Revenue Contributed remained flat by 0.0% to 78.0% in Q3 2024 compared to the prior quarter. Year-over-year, this metric grew by 1.3%, from 77.0% to 78.0%.
An increase suggests the diagnostics segment is growing faster than other business units, while a decrease indicates diversification or faster growth elsewhere.
This metric represents the proportion of total consolidated revenue generated by the Diagnostics business segment. It hi...
Commonly reported as segment revenue share in diversified healthcare and laboratory services firms.
lh_segment_labcorp_diagnostics_percent_of_revenue_contributed| Q2 '21 | Q3 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q1 '24 | Q2 '24 | Q3 '24 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | 61% | 64% | 63% | 77% | 77% | 78% | 77% | 77% | 78% | 78% | 78% |
| QoQ Change | — | +4.9% | -1.6% | +22.2% | +0.0% | +1.3% | -1.3% | +0.0% | +1.3% | +0.0% | +0.0% |
| YoY Change | — | — | — | +26.2% | +20.3% | +23.8% | +0.0% | +0.0% | +0.0% | +1.3% | +1.3% |